Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

References

• World Health Organization. Weekly Epidemiological Update on COVID-19-8 June 2022. World Health Organization; 2022.
   Google Scholar
• Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126–2128. doi:10.1016/S0140-6736(21)02758-6
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399(10340):2011–2012. doi:10.1016/S0140-6736(22)00838-8
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Krüger N, Schulz S, et al. The omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. 2022;185(3):447–56.e11. doi:10.1016/j.cell.2021.12.032
   PubMed Web of Science ®Google Scholar
• Del Rio C, Omer SB, Malani PN. Winter of omicron-the evolving COVID-19 pandemic. JAMA. 2022;327(4):319–320. doi:10.1001/jama.2021.24315
   PubMed Web of Science ®Google Scholar
• Silva S, Kohl A, Pena L, Pardee K. Recent insights into SARS-CoV-2 omicron variant. Rev Med Virol. 2022;33(1):e2373. doi:10.1002/rmv.2373
   PubMed Web of Science ®Google Scholar
• Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–1312. doi:10.1016/S0140-6736(22)00462-7
   PubMed Web of Science ®Google Scholar
• Publicity Department NHC. Transcript of the press conference of the joint prevention and control mechanism of the state council on march 19, 2022. Available from: http://www.nhc.gov.cn/xcs/fkdt/202203/a46803bba0964065ac8-74b6b43da21f5.shtml. Accessed May 2, 2022.
   Google Scholar
• General Office of National Health Commission. COVID-19 diagnosis and treatment protocol (trial version 9). Chin Med. 2022;17(04):481–487.
   Google Scholar
• Xin S, Cheng X, Zhu B, et al. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Biomed Pharmacother. 2020;129:110500. doi:10.1016/j.biopha.2020.110500
   PubMed Web of Science ®Google Scholar
• Hu K, Guan WJ, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2021;85:153242. doi:10.1016/j.phymed.2020.153242
   PubMed Web of Science ®Google Scholar
• Xiao M, Tian J, Zhou Y, et al. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial. Pharmacol Res. 2020;161:105126. doi:10.1016/j.phrs.2020.105126
   PubMed Web of Science ®Google Scholar
• Report M. WHO expert meeting on evaluation of traditional Chinese medicine in the treatment of COVID-19; 2022.
   Google Scholar
• (The state council information office of the People’s Republic of China: Shanghai held the press conference on the prevention and control of COVID-19 (the 138th) [EB/OL]; 2022. Available from: http://www.scio.gov.cn/m/xwfbh/gssxwfbh/xwfbh/shanghai/Document/1722607/1722607.htm.). Accessed March 17, 2023.
   Google Scholar
• Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. Advances in the omicron variant development. J Intern Med. 2022;292(1):81–90. doi:10.1111/joim.13478
   PubMed Web of Science ®Google Scholar
• Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY. Clinical outcomes associated with SARS-CoV-2 omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California. Nat Med. 2022;28(9):1933–1943. doi:10.1038/s41591-022-01887-z
   PubMed Web of Science ®Google Scholar
• Walsh KA, Jordan K, Clyne B, et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect. 2020;81(3):357–371. doi:10.1016/j.jinf.2020.06.067
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020;20(4):411–412. doi:10.1016/S1473-3099(20)30113-4
   PubMed Web of Science ®Google Scholar
• Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179. doi:10.1056/NEJMc2001737
   PubMed Web of Science ®Google Scholar
• Chen Y, Li L. SARS-CoV-2: virus dynamics and host response. Lancet Infect Dis. 2020;20(5):515–516. doi:10.1016/S1473-3099(20)30235-8
   PubMed Web of Science ®Google Scholar
• Bailly C. Atractylenolides, essential components of Atractylodes-based traditional herbal medicines: antioxidant, anti-inflammatory and anticancer properties. Eur J Pharmacol. 2021;891:173735. doi:10.1016/j.ejphar.2020.173735
   PubMed Web of Science ®Google Scholar
• Yang L, Yu H, Hou A, et al. A review of the ethnopharmacology, phytochemistry, pharmacology, application, quality control, processing, toxicology, and pharmacokinetics of the dried rhizome of Atractylodes macrocephala. Front Pharmacol. 2021;12:727154. doi:10.3389/fphar.2021.727154
   PubMed Web of Science ®Google Scholar
• Lee JC, Lee KY, Son YO, et al. Stimulating effects on mouse splenocytes of glycoproteins from the herbal medicine Atractylodes macrocephala Koidz. Phytomedicine. 2007;14(6):390–395. doi:10.1016/j.phymed.2006.09.012
   PubMed Web of Science ®Google Scholar
• Zhu B, Zhang QL, Hua JW, Cheng WL, Qin LP. The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: a review. J Ethnopharmacol. 2018;226:143–167. doi:10.1016/j.jep.2018.08.023
   PubMed Web of Science ®Google Scholar
• Zhu JZ, Leng ER, Chen DF. Promoting gastrointestinal motility of traditional Chinese medicine. World J Chin Digest. 1999;08:689–690.
   Google Scholar